PH22108A - Dna encoding human tumor necrosis factor and human tumor necrosis factor polypeptide - Google Patents
Dna encoding human tumor necrosis factor and human tumor necrosis factor polypeptideInfo
- Publication number
- PH22108A PH22108A PH31937A PH31937A PH22108A PH 22108 A PH22108 A PH 22108A PH 31937 A PH31937 A PH 31937A PH 31937 A PH31937 A PH 31937A PH 22108 A PH22108 A PH 22108A
- Authority
- PH
- Philippines
- Prior art keywords
- necrosis factor
- tumor necrosis
- human tumor
- dna encoding
- polypeptide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/525—Tumour necrosis factor [TNF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/034—Fusion polypeptide containing a localisation/targetting motif containing a motif for targeting to the periplasmic space of Gram negative bacteria as a soluble protein, i.e. signal sequence should be cleaved
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP59043617A JPS60185799A (ja) | 1984-03-06 | 1984-03-06 | ヒト癌壊死因子 |
JP59082653A JPS60232097A (ja) | 1984-04-23 | 1984-04-23 | ヒト癌壊死因子ポリペプチドの製造法 |
JP59172307A JP2584206B2 (ja) | 1984-08-17 | 1984-08-17 | ヒト癌壊死因子 |
Publications (1)
Publication Number | Publication Date |
---|---|
PH22108A true PH22108A (en) | 1988-06-01 |
Family
ID=27291610
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PH31937A PH22108A (en) | 1984-03-06 | 1985-03-04 | Dna encoding human tumor necrosis factor and human tumor necrosis factor polypeptide |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0155549B1 (de) |
KR (1) | KR920010225B1 (de) |
AU (1) | AU584608B2 (de) |
CA (1) | CA1341240C (de) |
DE (2) | DE19975063I2 (de) |
DK (1) | DK172013B1 (de) |
ES (2) | ES8802159A1 (de) |
FR (1) | FR99C0037I2 (de) |
HU (1) | HU202921B (de) |
NL (1) | NL990034I2 (de) |
PH (1) | PH22108A (de) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60112718A (ja) * | 1983-11-21 | 1985-06-19 | Kyorin Pharmaceut Co Ltd | 抗腫瘍作用を示す蛋白性物質及びその製造方法 |
JPH0695939B2 (ja) * | 1983-12-02 | 1994-11-30 | 大日本製薬株式会社 | ウサギ癌壊死因子をコ−ドするクロ−ン化dνa |
US4879226A (en) * | 1984-04-06 | 1989-11-07 | Asahi Kasei Kogyo Kabushiki Kaisha | Novel human physiologically active polypeptide |
US6686455B1 (en) | 1984-07-05 | 2004-02-03 | Genentech, Inc. | Tumor necrosis factor |
GR851626B (de) * | 1984-07-05 | 1985-11-26 | Genentech Inc | |
US5672347A (en) * | 1984-07-05 | 1997-09-30 | Genentech, Inc. | Tumor necrosis factor antagonists and their use |
AU589919B2 (en) * | 1984-10-15 | 1989-10-26 | Cetus Corp | Human tumor necrosis factor |
US4959314A (en) | 1984-11-09 | 1990-09-25 | Cetus Corporation | Cysteine-depleted muteins of biologically active proteins |
EP0216786B1 (de) * | 1984-12-21 | 1992-03-18 | Biogen, Inc. | Reinigung, herstellung und verwendung von tumor-nekrosisfaktoren |
JPS6248634A (ja) * | 1985-07-23 | 1987-03-03 | Mochida Pharmaceut Co Ltd | 新規アミノ酸組成物、その製造方法及び該アミノ酸組成物を含有する医療組成物 |
JPH064675B2 (ja) * | 1985-07-29 | 1994-01-19 | 伝一 水野 | 抗腫瘍性ポリペプチド |
US5059530A (en) * | 1985-09-30 | 1991-10-22 | Suntory Ltd. | Expression vector for human TNF |
JPH0698004B2 (ja) * | 1985-09-30 | 1994-12-07 | サントリー株式会社 | Tnf発現用新規プラスミド |
US4894439A (en) * | 1986-05-22 | 1990-01-16 | Cetus Corporation | N-terminal derivatives of tumor necrosis factor purified by microporous PTFE membranes |
US4677197A (en) * | 1985-10-30 | 1987-06-30 | Cetus Corporation | Purification method for tumor necrosis factor |
CA1286843C (en) * | 1985-10-30 | 1991-07-23 | Leo S. Lin | Purification method for proteins |
US5081021A (en) * | 1986-02-04 | 1992-01-14 | Mizuno Den Ichi | DNA encoding HTNF variants exhibiting enhanced activity |
KR940005589B1 (ko) * | 1986-04-02 | 1994-06-21 | 다이닛뽄세이야꾸 가부시끼가이샤 | 핵산 또는 엔도톡신의 제거제 및 제거방법 |
US5425940A (en) * | 1986-04-09 | 1995-06-20 | Cetus Oncology Corporation | Combination therapy using interleukin-2 and tumor necrosis factor |
DE3750056T2 (de) * | 1986-06-20 | 1995-04-06 | Dainippon Pharmaceutical Co | Polypeptid-Mutanten des menschlichen TNF und für diese Mutanten codierende DNS. |
AU1346488A (en) * | 1987-02-26 | 1988-09-26 | Cetus Corporation | Arginine-depleted human tumor necrosis factor |
DE3716513A1 (de) * | 1987-05-16 | 1988-11-24 | Basf Ag | Proteine mit tnf-wirkung |
JP2828988B2 (ja) * | 1988-04-03 | 1998-11-25 | 源一郎 杣 | 新規dnaとその生産方法、それを有する新規プラスミド、新規ポリペプチドとその生産方法、及び該ポリペプチドからなる新規抗腫瘍剤 |
GB2217325B (en) * | 1988-04-08 | 1991-11-20 | British Bio Technology | Synthetic gene for tumour necrosis factor alpha. |
JPH0797997B2 (ja) * | 1988-04-28 | 1995-10-25 | 帝人株式会社 | 新規生理活性ポリペプチド |
DE3843534A1 (de) * | 1988-12-23 | 1990-07-12 | Basf Ag | Neue tnf-polypeptide |
US5843693A (en) * | 1989-08-16 | 1998-12-01 | Chiron Corporation | Assay method for screening for inhibitors of proTNF conversion |
US6586222B1 (en) | 1989-08-16 | 2003-07-01 | Chiron Corporation | Recombinant PR-3 and compositions thereof |
US5998378A (en) * | 1989-08-16 | 1999-12-07 | Chiron Corporation | Compositions for the inhibition of TNF hormone formation and uses thereof |
EP0491878B1 (de) | 1989-08-16 | 1997-02-19 | Chiron Corporation | Zusammensetzungen zur hemmung der bildung von proteinhormon und deren verwendungen |
WO1991017180A1 (en) * | 1990-04-27 | 1991-11-14 | Peptide Technology Ltd | Peptides derived from human tumour necrosis factor alpha and useful against intracellular malarial parasites |
KR970005042B1 (ko) * | 1993-02-09 | 1997-04-11 | 한일합성섬유공업 주식회사 | 종양괴사인자-알파 뮤테인 |
CA2119089A1 (en) * | 1993-03-29 | 1994-09-30 | David Banner | Tumor necrosis factor muteins |
CA2185162A1 (en) | 1994-03-07 | 1995-09-14 | Robert F. Halenback (Deceased) | Compositions for the inhibition of tnf formation and uses thereof |
US6395273B1 (en) | 1998-06-10 | 2002-05-28 | Promega Corporation | Prevention and treatment of inflammatory bowel disease |
ES2151403B1 (es) * | 1998-07-13 | 2001-07-01 | Hernandez Bronchud Miguel | Linea celular transformada de rata productora de tnf-alfa humano recombinante. |
US20030086903A1 (en) | 2001-11-02 | 2003-05-08 | Genvec, Inc. | Therapeutic regimen for treating cancer |
DK2953634T3 (da) | 2013-02-07 | 2021-08-30 | Massachusetts Gen Hospital | Fremgangsmåder til udvidelse eller udtømning af regulerende t-celler |
WO2020210784A1 (en) | 2019-04-12 | 2020-10-15 | Ecolab Usa Inc. | Antimicrobial multi-purpose cleaner and methods of making and using the same |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4879226A (en) * | 1984-04-06 | 1989-11-07 | Asahi Kasei Kogyo Kabushiki Kaisha | Novel human physiologically active polypeptide |
JPS60260522A (ja) * | 1984-06-07 | 1985-12-23 | Asahi Chem Ind Co Ltd | 遺伝子組換体が生産する生理活性物質の安定化法 |
GR851626B (de) * | 1984-07-05 | 1985-11-26 | Genentech Inc | |
AU589919B2 (en) * | 1984-10-15 | 1989-10-26 | Cetus Corp | Human tumor necrosis factor |
JPS61124392A (ja) * | 1984-11-22 | 1986-06-12 | Asahi Chem Ind Co Ltd | 遺伝子組換体の産生する生理活性物質の精製法 |
-
1985
- 1985-02-26 EP EP85102093A patent/EP0155549B1/de not_active Expired - Lifetime
- 1985-02-26 DE DE1999175063 patent/DE19975063I2/de active Active
- 1985-02-26 DE DE8585102093T patent/DE3582183D1/de not_active Expired - Lifetime
- 1985-03-01 AU AU39448/85A patent/AU584608B2/en not_active Expired
- 1985-03-04 CA CA000475653A patent/CA1341240C/en not_active Expired - Lifetime
- 1985-03-04 PH PH31937A patent/PH22108A/en unknown
- 1985-03-05 HU HU85828A patent/HU202921B/hu unknown
- 1985-03-05 ES ES540939A patent/ES8802159A1/es not_active Expired
- 1985-03-05 KR KR1019850001374A patent/KR920010225B1/ko not_active IP Right Cessation
- 1985-03-05 DK DK100985A patent/DK172013B1/da not_active IP Right Cessation
-
1986
- 1986-01-16 ES ES550939A patent/ES8703490A1/es not_active Expired
-
1999
- 1999-10-12 NL NL990034C patent/NL990034I2/nl unknown
- 1999-10-12 FR FR99C0037C patent/FR99C0037I2/fr active Active
Also Published As
Publication number | Publication date |
---|---|
ES8802159A1 (es) | 1988-04-01 |
KR850006874A (ko) | 1985-10-21 |
ES8703490A1 (es) | 1987-02-16 |
HU202921B (en) | 1991-04-29 |
DK172013B1 (da) | 1997-09-15 |
DK100985A (da) | 1985-09-07 |
HUT37957A (en) | 1986-03-28 |
DE19975063I1 (de) | 2005-07-14 |
FR99C0037I1 (de) | 1999-12-10 |
EP0155549A2 (de) | 1985-09-25 |
ES550939A0 (es) | 1987-02-16 |
DE19975063I2 (de) | 2005-08-18 |
KR920010225B1 (ko) | 1992-11-21 |
DK100985D0 (da) | 1985-03-05 |
CA1341240C (en) | 2001-06-05 |
EP0155549B1 (de) | 1991-03-20 |
EP0155549A3 (en) | 1986-12-30 |
FR99C0037I2 (de) | 2000-10-27 |
NL990034I1 (nl) | 1999-12-01 |
AU3944885A (en) | 1985-09-12 |
DE3582183D1 (de) | 1991-04-25 |
NL990034I2 (nl) | 2000-11-01 |
ES540939A0 (es) | 1988-04-01 |
AU584608B2 (en) | 1989-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH22108A (en) | Dna encoding human tumor necrosis factor and human tumor necrosis factor polypeptide | |
GB2158829B (en) | Human tumor necrosis factor and dna therefor | |
EP0183350A3 (en) | Dna endcoding human colony stimulating factor, peptide encoded thereby,vectors and transformed hosts containing such dna, and the production of all thereof | |
GB8819209D0 (en) | Polypeptide & dna encoding same | |
PT78773A (en) | The effect of human tumor necrosis factor and human interferon on human cancer cells and methods | |
EP0162699A3 (en) | Interleukin-2 receptor and dna encoded therefor and their preparation | |
AU5010685A (en) | Human tumor necrosis factor | |
EP0161901A3 (en) | Human il-1 cdna sequences encoding biologically-active human il-1 proteins | |
IL83930A0 (en) | Purification of recombinant tumor necrosis factor | |
GB2164044B (en) | -hanp related polypeptides and their use | |
EP0195592A3 (en) | Factor ix protein | |
EP0164273A3 (en) | New peptide and gene coding for same | |
ZA862479B (en) | Recombinant human renin | |
ZA857906B (en) | Human tumor necrosis factor | |
GB8929110D0 (en) | Polypeptides and dna encoding therefor | |
GR890100185A (en) | Novel polypeptides having growth factor activity and nucleic acid sequences encoding the polypeptides | |
PH24603A (en) | Novel polypeptides having growth factor activity and nucleic acid sequences encoding the polypeptides | |
IL74094A0 (en) | Highly solubilised protein and production thereof | |
EP0378676A4 (en) | Tumor necrosis enhancing factor and methods of preparation and use | |
ZA9010036B (en) | Expression of the recombinant tumor necrosis factor binding protein i(tbp-i) | |
ZA854295B (en) | New peptide and gene coding for same | |
ATE61817T1 (de) | Dns den menschlichen tumornekrosisfaktor kodierend und das menschliche tumornekronisfaktor-polypeptid. | |
HRP950156B1 (en) | Tumor necrosis factor | |
ZA855059B (en) | Tumor necrosis factor | |
IL89010A0 (en) | Human tumor necrosis factor |